BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 6427417)

  • 1. The biology and treatment of superficial bladder cancer.
    Torti FM; Lum BL
    J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS; Jordan AM; Murphy WM
    Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches including interferon to carcinoma in situ of the bladder.
    Lum BL; Torti FM
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():45-59. PubMed ID: 2421897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts in the management of superficial bladder cancer.
    Soloway MS
    Arch Esp Urol; 1990; 43 Suppl 2():115-21. PubMed ID: 2129003
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical chemotherapy. Treatment selection, techniques, and results.
    Richie JP
    Urol Clin North Am; 1992 Aug; 19(3):521-7. PubMed ID: 1636236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of superficial bladder cancer with intravesical chemotherapy.
    Badalament RA; Farah RN
    Semin Surg Oncol; 1997; 13(5):335-41. PubMed ID: 9259089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant intravesical therapy for superficial bladder cancer.
    Batts CN
    Ann Pharmacother; 1992 Oct; 26(10):1270-6. PubMed ID: 1421654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting initial therapy for bladder cancer.
    Soloway MS
    Cancer; 1987 Aug; 60(3 Suppl):502-13. PubMed ID: 3109725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing superficial bladder cancer: an overview.
    Soloway MS
    Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical chemotherapy: how effective is it?
    Heney NM
    Urology; 1988 Mar; 31(3 Suppl):17-9. PubMed ID: 3126591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment modalities in superficial bladder cancer.
    Irwin R; Zincke H; Droller MJ; Prout GR; Soloway MS
    Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravesical chemotherapy of superficial bladder tumors].
    Matsumura Y
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Superficial bladder cancer: prophylaxis of recurrence and progression].
    Miyanaga N; Akaza H; Koiso K
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.